Pfizer Inc. (PFE) Social Stream
PFIZER INC (PFE) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering PFIZER INC.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-11-08 | 11 | $61 | $41 | $47.6 | $33.99 | 40.04% |
2021-11-14 | 10 | $61 | $41 | $47.6 | $33.99 | 40.04% |
2021-11-19 | 11 | $61 | $41 | $48.727 | $33.99 | 43.36% |
2021-11-23 | 11 | $61 | $41 | $50.09 | $33.99 | 47.37% |
2021-11-29 | 11 | $61 | $41 | $52 | $33.99 | 52.99% |
2021-12-09 | 13 | $61 | $41 | $52.666 | $33.99 | 54.95% |
2021-12-14 | 14 | $61 | $41 | $54.642 | $33.99 | 60.76% |
2021-12-15 | 14 | $61 | $41 | $55.214 | $33.99 | 62.44% |
2021-12-17 | 13 | $75 | $41 | $56.214 | $33.99 | 65.38% |
2022-01-04 | 13 | $75 | $41 | $57.571 | $33.99 | 69.38% |
2022-01-05 | 13 | $75 | $41 | $58.357 | $33.99 | 71.69% |
2022-01-24 | 12 | $75 | $41 | $58.923 | $33.99 | 73.35% |
2022-01-28 | 12 | $75 | $41 | $59.23 | $33.99 | 74.26% |
2022-02-09 | 12 | $75 | $44 | $60.75 | $33.99 | 78.73% |
2022-04-22 | 12 | $75 | $44 | $61.181 | $33.99 | 80% |
2022-05-02 | 12 | $75 | $44 | $60.666 | $33.99 | 78.48% |
2022-05-04 | 12 | $75 | $44 | $59.833 | $33.99 | 76.03% |
2022-05-14 | 12 | $75 | $44 | $59.583 | $33.99 | 75.3% |
2022-06-15 | 12 | $75 | $44 | $59.23 | $33.99 | 74.26% |
2022-06-22 | 12 | $75 | $52 | $60.5 | $33.99 | 77.99% |
2022-07-29 | 12 | $75 | $49 | $59.416 | $33.99 | 74.8% |
2022-08-25 | 12 | $75 | $49 | $59.25 | $33.99 | 74.32% |
2022-10-05 | 12 | $75 | $49 | $58.833 | $33.99 | 73.09% |
2022-10-12 | 12 | $75 | $48 | $57.833 | $33.99 | 70.15% |
2022-10-13 | 12 | $75 | $44 | $57.25 | $33.99 | 68.43% |
2022-11-01 | 12 | $75 | $44 | $56.833 | $33.99 | 67.21% |
2022-11-02 | 12 | $75 | $44 | $56.75 | $33.99 | 66.96% |
2022-11-03 | 12 | $75 | $49 | $57.333 | $33.99 | 68.68% |
2022-12-08 | 11 | $75 | $49 | $57.09 | $33.99 | 67.96% |
2022-12-12 | 12 | $75 | $49 | $56.8 | $33.99 | 67.11% |
2022-12-13 | 12 | $75 | $49 | $57.2 | $33.99 | 68.28% |
2023-01-03 | 11 | $75 | $49 | $57.4 | $33.99 | 68.87% |
2023-01-17 | 11 | $75 | $49 | $57.4 | $33.99 | 68.87% |
2023-01-18 | 11 | $75 | $49 | $57 | $33.99 | 67.7% |
2023-01-27 | 12 | $75 | $49 | $57 | $33.99 | 67.7% |
2023-02-01 | 14 | $75 | $47 | $55.166 | $33.99 | 62.3% |
2023-02-27 | 14 | $75 | $44 | $52.846 | $33.99 | 55.48% |
2023-03-06 | 15 | $75 | $43 | $52.142 | $33.99 | 53.4% |
2023-03-17 | 15 | $75 | $41 | $52 | $33.99 | 52.99% |
2023-04-04 | 15 | $75 | $41 | $51.928 | $33.99 | 52.77% |
2023-04-10 | 15 | $75 | $41 | $51.857 | $33.99 | 52.57% |
2023-04-13 | 15 | $75 | $41 | $51.785 | $33.99 | 52.35% |
2023-04-18 | 15 | $75 | $41 | $50.928 | $33.99 | 49.83% |
2023-05-02 | 15 | $75 | $41 | $50.571 | $33.99 | 48.78% |
2023-05-03 | 15 | $75 | $40 | $50.142 | $33.99 | 47.52% |
2023-05-16 | 14 | $75 | $39 | $49.571 | $33.99 | 45.84% |
2023-06-06 | 15 | $75 | $38 | $48.8 | $33.99 | 43.57% |
2023-06-26 | 15 | $75 | $38 | $48.733 | $33.99 | 43.37% |
2023-07-03 | 15 | $75 | $38 | $48.733 | $33.99 | 43.37% |
2023-07-11 | 16 | $75 | $38 | $48.733 | $33.99 | 43.37% |
2023-07-14 | 16 | $75 | $38 | $48.687 | $33.99 | 43.24% |
2023-07-17 | 16 | $75 | $38 | $48.437 | $33.99 | 42.5% |
2023-07-21 | 16 | $75 | $38 | $47.937 | $33.99 | 41.03% |
2023-08-01 | 16 | $75 | $38 | $47.875 | $33.99 | 40.85% |
2023-08-02 | 16 | $75 | $38 | $47.687 | $33.99 | 40.3% |
2023-09-06 | 16 | $75 | $38 | $47 | $33.99 | 38.28% |
The Trend in the Analyst Price Target
Over the past 17 months, PFE's average price target has gone down $13.67.
Over the past 50 weeks, PFE's average upside potential has been 26.04%.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2022-10-13 | 12 | 75 | 44 | 57.250 | 42.96 | 33.26% |
2022-11-02 | 12 | 75 | 44 | 56.750 | 47.07 | 20.57% |
2022-12-08 | 11 | 75 | 49 | 57.090 | 51.78 | 10.25% |
2022-12-13 | 12 | 75 | 49 | 57.200 | 53.07 | 7.78% |
2023-05-02 | 15 | 75 | 41 | 50.571 | 39.06 | 29.47% |
PFE Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
2.19 | 6 | 1 | 9 | 0 | 0 | 16 |
The Trend in the Broker Recommendations
Over the past 35 weeks, PFE's average broker recommendation rating worsened by 0.28.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PFE as an investment opportunity.
- In terms of how PFIZER INC fares relative to stocks in the mega market cap category, note that its upside potential (average analyst target price relative to current price) is higher than 5339.75% of that group.
- In terms of how PFIZER INC fares relative to stocks in the mega market cap category, note that its average analyst price target is higher than 777.19% of that group.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, PFIZER INC's number of analysts covering the stock is higher than 5070.37% of them.
- PFIZER INC's variance in analysts' estimates is lower than -3835.18% of stocks in the mega market cap category.
Stocks similar to PFIZER INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are LLY, ABT, and BNTX.
View All Top Stocks by Price Target
Is PFE a Buy, Hold or Sell? See the POWR Ratings now!